← Evidence map

ArticleAlimentary pharmacology & therapeutics2017

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.

A N Ananthakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28470787